1
Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease
Condition(s):SafetyLast Updated:December 13, 2013Completed
Azilsartan Medoxomil and Chlorthalidone: 12 Clinical Trials, Page 1 of 2
Hide Studies Not Open or Pending
2
Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.
Condition(s):Essential HypertensionLast Updated:February 7, 2012Completed
3
Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension
Condition(s):Essential HypertensionLast Updated:February 7, 2012Completed
4
A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone
Condition(s):Essential HypertensionLast Updated:April 23, 2014Completed
5
Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension
Condition(s):Essential HypertensionLast Updated:November 12, 2012Completed
6
Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension
Condition(s):Essential HypertensionLast Updated:March 13, 2012Completed
7
Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension
Condition(s):HypertensionLast Updated:April 19, 2011Completed
8
Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension
Condition(s):HypertensionLast Updated:February 7, 2012Completed
9
Observational Study of Azilsartan/Chlorthalidone and Irbesartan/Hydrochlorothiazide in Hypertension and Obesity.
Condition(s):Arterial HypertensionLast Updated:October 19, 2020Completed
10
A Study for Post-marketing Surveillance of Azilsartan Medoxomil/Chlorthalidone Fixed Dose Combination (FDC) in the Treatment of Participants With Essential Hypertension in South Korea
Condition(s):Essential HypertensionLast Updated:July 22, 2020Recruiting